Federated Hermes’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.48K Hold
3,527
﹤0.01% 1901
2025
Q4
$8.43K Buy
+3,527
New +$9.64K ﹤0.01% 1849
2021
Q4
Sell
-61,370
Closed -$3.07M 2242
2021
Q3
$3.07M Sell
61,370
-51,620
-46% -$2.82M 0.01% 939
2021
Q2
$6.27M Sell
112,990
-174
-0.2% -$9.27K 0.01% 782
2021
Q1
$5.29M Buy
+113,164
New +$5.48M 0.01% 839

Other funds holding HCAT

Federated Hermes's HCAT Position: Q1 2026 in Review

Federated Hermes held its Health Catalyst (HCAT) position steady in Q1 2026 at 3,527 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #1901.

Federated Hermes first reported a position in HCAT in Q1 2021 and has held it in 5 quarters since. The position peaked at $6.27M in Q2 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Federated Hermes held 3,527 shares of Health Catalyst worth $4.48K as of Q1 2026.
  • Federated Hermes left its Health Catalyst share count unchanged in Q1 2026.
  • Health Catalyst made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1901 holding.
  • Federated Hermes first reported a position in Health Catalyst in Q1 2021 and has held it in 5 quarters since.
  • Federated Hermes's Health Catalyst position peaked at $6.27M in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.